CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration
Science Advances · 2024
DOI: 10.1126/sciadv.adn5417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Qinfang Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Connecticut School of Medicine, Farmington, CT 06030, USA. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Guanine Nucleotide Exchange Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Mutations in LRRK2 are the most common genetic cause of Parkinson’s disease (PD). LRRK2 protein contains two enzymatic domains: a GTPase (Roc-COR) and a kinase domain. Disease-causing mutations are found in both domains. Now, studies have focused largely on LRRK2 kinase activity, while attention to its GTPase function is limited. LRRK2 is a guanine nucleotide–binding protein, but the mechanism of direct regulation of its GTPase activity remains unclear and its physiological GEF is not known. Here, we identified CalDAG-GEFI (CDGI) as a physiological GEF for LRRK2. CDGI interacts with LRRK2 and increases its GDP to GTP exchange activity. CDGI modulates LRRK2 cellular functions and LRRK2-induced neurodegeneration in both LRRK2 Drosophila and mouse models. Together, this study identified the physiological GEF for LRRK2 and provides strong evidence that LRRK2 GTPase is regulated by GAPs and GEFs. The LRRK2 GTPase, GAP, or GEF activities have the potential to serve as therapeutic targets, which is distinct from the direct LRRK2 kinase inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
- Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT 06269, USA.
- McGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
ORCID-Profile: Qinfang Liu, Dong Zhu, Jianzhong Yu, Ann M Graybiel, Ted M Dawson, Valina L Dawson, Yulan Xiong
Förderung
- NIGMS NIH HHS
- NIA NIH HHS
- NIMH NIH HHS
- NINDS NIH HHS
Zitieren
APA
Liu, Q., Huang, B., Guiberson, N. G. L., Chen, S., Zhu, D., Ma, G., Ma, X. M., Crittenden, J. R., Yu, J., Graybiel, A. M., Dawson, T. M., Dawson, V. L., & Xiong, Y. (2024). CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration. Science Advances. https://doi.org/10.1126/sciadv.adn5417
Vancouver
Liu Q, Huang B, Guiberson NGL, Chen S, Zhu D, Ma G, et al. CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration. Science Advances. 2024. doi:10.1126/sciadv.adn5417
BibTeX
@article{Liu2024,
author = {Liu, Qinfang and Huang, Bingxu and Guiberson, Noah Guy Lewis and Chen, Shifan and Zhu, Dong and Ma, Gang and Ma, Xin-Ming and Crittenden, Jill R and Yu, Jianzhong and Graybiel, Ann M and Dawson, Ted M and Dawson, Valina L and Xiong, Yulan},
title = {CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adn5417}
}
EUVIMED